Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Country and Growth Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering. The Asia Pacific Insulin Syringes Market is expected to witness market growth of 6.1% CAGR during the forecast period (2021-2027). Insulin syringes are widely used among diabetic patients for easier diabetes care, with around 40% of patients injecting insulin using these syringes. Insulin syringes are single-use disposable devices. This ensures that the needles are sterile, reducing the danger of infection from previously used needles. To minimize lipohypertrophy, or an abnormal fat accumulation under the skin, it's also necessary to rotate injection sites. With daily insulin shots, it's a frequent problem. Insulin is injected subcutaneously - that is, just under the skin - to avoid the needle puncturing muscle, which might alter the blood sugar levels. As the prevalence of diabetes rises, so will the need for insulin, which will have a favourable impact on market growth. Patients are increasingly using portable tools like insulin syringes for more convenient diabetes care, with roughly 40.0 percent of diabetics injecting insulin with syringes. In China, unhealthy diets and a lack of physical activity are contributing to rising rates of overweight and obesity, both of which are risk factors for Type 2 diabetes. In China, more than a third of adults are overweight, with 7% of persons being obese. Youngsters in China are also at danger of acquiring diabetes as a result of unhealthy lifestyles: more than 4 in 5 teenagers aged 11 to 17 do not receive adequate physical activity, and obesity in children are fast rising. As a result, increased diabetes cases will propel the Insulin Syringes Market forward. The China market dominated the Asia Pacific Insulin Syringes Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $182 million by 2027. The Japan market is anticipated to grow a CAGR of 5.6% during (2021 - 2027). Additionally, The India market is expected to showcase a CAGR of 6.8% during (2021 - 2027). Based on Disease, the market is segmented into Type 2 Diabetes and Type 1 Diabetes. Based on Syringe Size, the market is segmented into 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1CC Syringe (1ml) and Others. Based on End User, the market is segmented into Hospitals & Clinics, Homecare Settings, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hindustan Syringes & Medical Devices Ltd., Novo Nordisk A/S, Biocon Limited, Eli Lilly and Company, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health, Inc., Medline Industries, Inc., Terumo Corporation, and Nipro Corporation. Key Topics Covered: Chapter 1. Market Scope & Methodology Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.1.1 Market Composition and Scenario 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints Chapter 3. Asia Pacific Insulin Syringes Market by Disease 3.1 Asia Pacific Type 2 Diabetes Market by Country 3.2 Asia Pacific Type 1 Diabetes Market by Country Chapter 4. Asia Pacific Insulin Syringes Market by Syringe Size 4.1 Asia Pacific 3/10 CC Syringe (0.3ml) Market by Country 4.2 Asia Pacific 1/2 CC Syringe (0.5ml) Market by Country 4.3 Asia Pacific 1CC Syringe (1ml) Market by Country 4.4 Asia Pacific Other Syringe Size Market by Country Chapter 5. Asia Pacific Insulin Syringes Market by End User 5.1 Asia Pacific Hospitals & Clinics Market by Country 5.2 Asia Pacific Homecare Settings Market by Country 5.3 Asia Pacific Others Market by Country Chapter 6. Asia Pacific Insulin Syringes Market by Country 6.1 China Insulin Syringes Market 6.1.1 China Insulin Syringes Market by Disease 6.1.2 China Insulin Syringes Market by Syringe Size 6.1.3 China Insulin Syringes Market by End User 6.2 Japan Insulin Syringes Market 6.2.1 Japan Insulin Syringes Market by Disease 6.2.2 Japan Insulin Syringes Market by Syringe Size 6.2.3 Japan Insulin Syringes Market by End User 6.3 India Insulin Syringes Market 6.3.1 India Insulin Syringes Market by Disease 6.3.2 India Insulin Syringes Market by Syringe Size 6.3.3 India Insulin Syringes Market by End User 6.4 South Korea Insulin Syringes Market 6.4.1 South Korea Insulin Syringes Market by Disease 6.4.2 South Korea Insulin Syringes Market by Syringe Size 6.4.3 South Korea Insulin Syringes Market by End User 6.5 Singapore Insulin Syringes Market 6.5.1 Singapore Insulin Syringes Market by Disease 6.5.2 Singapore Insulin Syringes Market by Syringe Size 6.5.3 Singapore Insulin Syringes Market by End User 6.6 Malaysia Insulin Syringes Market 6.6.1 Malaysia Insulin Syringes Market by Disease 6.6.2 Malaysia Insulin Syringes Market by Syringe Size 6.6.3 Malaysia Insulin Syringes Market by End User 6.7 Rest of Asia Pacific Insulin Syringes Market 6.7.1 Rest of Asia Pacific Insulin Syringes Market by Disease 6.7.2 Rest of Asia Pacific Insulin Syringes Market by Syringe Size 6.7.3 Rest of Asia Pacific Insulin Syringes Market by End User Chapter 7. Company Profiles 7.1 Hindustan Syringes & Medical Devices Ltd. 7.1.1 Company Overview 7.2 Novo Nordisk A/S 7.2.1 Company Overview 7.2.2 Financial Analysis 7.2.3 Segmental & Regional Analysis 7.2.4 Research & Development Expenses 7.2.1 Recent strategies and developments: 7.2.1.1 Acquisitions and Mergers: 7.3 Biocon Limited 7.3.1 Company Overview 7.3.2 Recent strategies and developments: 7.4 Eli Lilly and Company 7.4.1 Company Overview 7.4.2 Financial Analysis 7.4.3 Regional Analysis 7.4.4 Research & Development Expense 7.4.5 Recent Strategies and Developments: 7.4.5.1 Partnerships, Collaborations, and Agreements: 7.4.5.2 Product Launches and Product Expansions: 7.4.5.3 Approvals and Trials: 7.5 Abbott Laboratories 7.5.1 Company Overview 7.5.2 Financial Analysis 7.5.3 Segmental and Regional Analysis 7.5.4 Research & Development Expense 7.5.5 Recent strategies and developments: 7.5.5.1 Partnerships, Collaborations, and Agreements: 7.6 Becton, Dickinson and Company 7.6.1 Company Overview 7.6.2 Financial Analysis 7.6.3 Segmental and Regional Analysis 7.6.4 Research & Development Expense 7.6.5 Recent strategies and developments: 7.6.5.1 Approvals and Trials: 7.9 Terumo Corporation 7.9.1 Company Overview 7.9.2 Financial Analysis 7.9.3 Segmental Analysis 7.10. Nipro Corporation 7.10.1 Company Overview 7.10.2 Financial Analysis 7.10.3 Segmental and Regional Analysis 7.10.4 Research & Development Expenses For more information about this report visit https://www.researchandmarkets.com/r/tbltpq
Old Navy and Gap continue to face challenges, while Banana Republic is showing signs of life again as its rebranding begins to resonate.
The technology sector is composed of businesses that sell goods and services in electronics, software, computers, artificial intelligence (AI), and other industries related to information technology (IT). The sector includes companies with the largest market capitalizations in the world, such as Apple Inc., Microsoft Corp., and Amazon.com Inc. Tech stocks, represented by the Technology Select Sector SPDR Fund (XLK), have outperformed the broader market over the past year.
Do you need free transportation? Do you need advertising for your brand? GEST Carts Chicago has got you covered! Here's what co-owner Tiffany Shepard has to say.
After a long, dreary period of lingering close to zero, short-term yields are on the rise, so we asked advisors for their thoughts on the best places for clients to stash the cash portion of their portfolios. Richard Skae, vice chairman of Morgan Stanley Wealth Management Group, has died at age 65. Skae served as vice chair since 2017, and was credited as “absolutely instrumental to the success of our firm” by Andy Saperstein, co-president of Morgan Stanley and head of the wealth management division.
The dollar edged lower on Friday on its way to a second-straight weekly decline as traders pared expectations for U.S. Federal Reserve interest rate hikes and as improving inflation and consumer spending data eased recession fears. On a weekly basis, it was down 1.24%, following a 1.45% decline the previous week. The "Fed is fully priced and expectations for rate hikes later in the year may be subject to revision if the economy slows more quickly than expected," they said.
Ankiti Bose cofounded the Singapore-based startup Zilingo to connect small businesses, and it scaled up rapidly. An ongoing probe over financial irregularities led to her suspension and termination.
A growth-stock investor makes the case for a return to form in small-cap growth stocks. Plus, Broadcom and the chip shortage, Snap and internet advertising, and Thomas Peterffy on zero-commission trading.
Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and the reward potentials – than penny stocks. These equities, priced below $5 per share, typically offer high upside potentials. Even a small gain in share price – just a few cents – quickly translates into a high yield return. Of course, the risk is real, too; not every penny stock is going to show th
Advance planning and a little discipline can keep you out of wedding debt.
One River’s initial application faced a delay in March.
Aurora Cannabis Inc. shares dropped 28% Friday after the cannabis company said it would increase the size of its bought deal financing to $150 million from $125 million. A syndicate of underwriters led by Canaccord Genuity and BMO Capital Markets will buy on a bought deal basis 61.2 million units of the company at a price of $2.45 per unit for gross proceeds of approximately $150 million. Each Unit will be comprised of one common share and one common share purchase warrant exercisable for 36 mon
Leesburg quantum computing software company Quantum Computing Inc. (NASDAQ: QUBT) is purchasing fellow quantum firm QPhoton Inc. in its first M&A deal. The acquisition will be paid for by a mixture of common stock, preferred stock and warrants and will represent in total approximately 49% of the total outstanding capital stock of QCI. Quantum Computing Inc., or QCI, began trading on the Nasdaq in July after three years on the over-the-counter market.
(Bloomberg) -- Baidu Inc. shares jumped more than 12% on Friday after the Chinese internet search leader posted a surprise quarterly revenue gain, reassuring investors spooked by the impact of Covid lockdowns.Most Read from BloombergFord Beats Tesla to the Punch With First Electric F-150 DeliveryUkraine Latest: US Slams Putin’s Food-for-Sanctions Relief PlanTop Gun: Maverick's F-18 Flights Cost New Tom Cruise Film $11,374 an HourRare Ship-to-Ship Transfers Keep Oil Moving From Russia to ChinaSal
Yes, shares in Zoom Video soared during the coronavirus crisis. But what's the outlook for Zoom stock as in-person meetings rebound and the pandemic fades.
Gasoline prices hovering at all-time-highs appear to be curbing some demand. But the cost for driving fuel is expected to stay high well into the summer.
In the second part of his question-and-answer session, WSP’s Earth and Environment leader looks at remediation regulations, wind and solar opportunities and more.
Odds that some of the biggest Russian corporations will default have soared to 80%, according to pricing in credit-default swaps
Ant Group, the fintech affiliate of Alibaba Group Holding, has granted billions of yuan in cash dividends to its shareholders for the first time since it brought in investors in 2015, according to Alibaba's latest quarterly financial report. Ant's dividends paid to Alibaba, which owns 33 per cent of the unicorn, amounted to 3.9 billion yuan (US$622 million), according to the earnings results of Alibaba, parent company of the South China Morning Post, published on Thursday. That means total divid
Panelists at our inaugural cryptocurrency roundtable offer bold predictions for Bitcoin, stablecoins, blockchain, and more.
The stock market selloff has made many stocks look cheap—but smart investors need to be selective. Here are six high-quality companies that trade at reasonable valuations.